Latest news
This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism? - StocktwitsStocktwits · Sat, 08 Aug 2026 07:16:55 GMTWilliam Blair Maintains Evommune(EVMN.US) With Hold Rating - MoomooMoomoo · Sat, 08 Aug 2026 02:46:42 GMTEvommune (NYSE:EVMN) Price Target Cut to $29.00 by Analysts at Royal Bank Of Canada - marketbeat.commarketbeat.com · Fri, 07 Aug 2026 19:33:22 GMTEvommune, Inc. Stock 12‑Month Price Target Cut to $30.11, Implies 125% Upside - TradingViewTradingView · Fri, 07 Aug 2026 17:20:41 GMTEvommune Inc (EVMN) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 14:32:29 GMTRBC Adjusts PT on Evommune to $29 From $30, Maintains Outperform Speculative Risk Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 12:55:38 GMTEVMN: Strong cash reserves support key clinical milestones despite higher losses and no Q2 revenue - TradingViewTradingView · Thu, 06 Aug 2026 20:24:31 GMTEvommune reports Q2 2026 net loss of $32.2M, cash $288.0M; EVO756 Phase 2b AD readout due Sept 2026 - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMT